By Lynx Insight Service
Oct 16 (Reuters) - * Trinity Biotech PLC TRIB.OQ TRIB.O
is expected to show a rise in quarterly revenue when it reports
results on October 19 (estimated).
* The Bray, Wicklow-based company is expected to report a
13.8% increase in revenue to $28 million from $24.59 million a
year ago, according to the mean estimate of 1 analysts, based on
Refinitiv data.
* The analyst mean estimate for Trinity Biotech PLC is for
earnings of $10.00 per share. For the same quarter last year,
the company reported earnings of 4 cents per share.
* Wall Street's median 12-month price target for Trinity Biotech
PLC is $5, about 47.2% above its last closing price of $2.64.
* Previous quarterly performance (using preferred earnings
measure)
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2019 0.06 0.09 Beat 50
Sep. 30 2019 0.06 0.06 0.04 Missed -28.3
Jun. 30 2019 0.07 0.00 Missed -97.1
Mar. 31 2019 0.07 0.07 0.01 Missed -92.9
Dec. 31 2018 0.04 0.04 0.07 Beat 75
Sep. 30 2018 0.06 0.06 0.05 Missed -15
This summary was machine generated October 16 at 11:49 GMT